跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ULTRA LIGHT ADVANCED CONTINUOUS SPRAY LOTION - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ULTRA LIGHT ADVANCED CONTINUOUS SPRAY LOTION
Authorized
STANDARD
ULTRA LIGHT ADVANCED CONTINUOUS SPRAY LOTION
ombrelle canada
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
631a0662923f3865
Company
ombrelle canada
Type
Standard
Approval Details
Approval Id
631a0662923f3865
Drug Approval Canada Name
ULTRA LIGHT ADVANCED CONTINUOUS SPRAY LOTION
Product Name
ULTRA LIGHT ADVANCED CONTINUOUS SPRAY LOTION
Status
Marketed
Status Date
2021-04-23
Original Market Date
2017-03-02
Din
02448718
Drug Class
Human
Dosage Form
Lotion
Route Of Administration
Topical
Schedule
OTC
Ahfs
84:80.00
Atc Original
D02BA30 COMBINATIONS OF PROTECTIVES AGAINST UV-RADIATION
Atc Name
d 02 ba 30
Aig Number
0552875005
Company Name
ombrelle canada
Company Address
4895 Hickmore, Montreal, Quebec, Canada, H4T 1K5
Active Ingredients
DROMETRIZOLE TRISILOXANE
0.5 % / W/W
AVOBENZONE
3 % / W/W
HOMOSALATE
15 % / W/W
OCTISALATE
5 % / W/W
OCTOCRYLENE
3 % / W/W
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
631a0662923f3865
Type
Standard
Back to Health Canada Approvals
